Company record
Lipomed Inc. develops and manufactures a broad portfolio of pharmaceutical products, including antineoplastic agents, steroids, vitamins, tablets, oral suspensions, alcohol and ethanol biomarkers, as well as deuterated analogues and other derivatives. Its formulations are aimed at treating rare diseases and hematologic cancer in adults, adolescents and children. Lipomed supplies these medicines to the medical and healthcare sectors.
This directory record does not yet have a linked material-flow brief.